In this edition of “Rising High,” The Fly conducted an exclusive interview with Doug Drysdale, Chief Executive Officer of Cybin (CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics. Here are some… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3616028/-Rising-High-Exclusive-talk-with-psychedelic-biopharma-firm-Cybin)
previous post
next post